Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by davikingon Apr 30, 2019 12:13pm

93 Views

Post# 29689178

RE:RE:Insight into the home market.

Interesting! Not sure what you mean by that but there seems to be a number of products related although only one that I could find that is portable for CRRT and Home Dialysis (ours for PMX as well).
Keep wondering why if there is such a need for a Sepsis treatment, it is taking so long. While researching a Quanta product vs Infomed's product, I came across this link:
https://www.acciusa.com/lal/index.html
Our EAA is not quite so special, it seems (FDA licensed and American-is EAA the ONLY FDA approved test???):
https://www.acciusa.com/acc/index.html

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide